A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter’s Transformation
Hodgkin lymphoma variant of Richter’s transformation (HvRT) is a rare complication for patients with chronic lymphocytic leukemia (CLL), with an overall poor prognosis. We present the first known case series of patients with HvRT treated with the combination of brentuximab vedotin, doxorubicin, vinb...
Saved in:
Main Authors: | Benjamin Heyman, Michael Choi, Thomas J. Kipps |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2024/7612622 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peripheral T Cell Non-Hodgkin’s Lymphoma following Treatment of Hodgkin’s Lymphoma
by: Sun Hee Chang, et al.
Published: (2015-01-01) -
Hypercalcemia in Small Lymphocytic Lymphoma with an Elevated Parathyroid Hormone-Related Peptide Associated with Early Richter Transformation
by: Ashish Bains, et al.
Published: (2021-01-01) -
Variant Guillain-Barré Syndrome in a Patient with Non-Hodgkin’s Lymphoma
by: R. H. Bishay, et al.
Published: (2015-01-01) -
Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma
by: Kheng-Wei Yeoh, et al.
Published: (2011-01-01) -
Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma
by: Hung-Bo Wu, et al.
Published: (2013-01-01)